Neuroprotective effects of acetyl-L-carnithine in experimental chronic compression neuropathy. A prospective, randomized and plasebo-control trials

Turkish Neurosurgery

Volumn 17, Issue 2, 2007, Pages 67-77

  Kotil, Kadir ^a   Kiral, Mehmet ^b   Eras, Mustafa ^a   Bilge, Turgay ^a   Uzun, Hafize ^a  

^a HASEKI EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Acetyl L carnithine; Chronic nerve compression; Neuroprotective effects

Indexed keywords

ETHER; LEVACECARNINE; PLACEBO; SILICON; ACETYLCARNITINE; NEUROPROTECTIVE AGENT; NOOTROPIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE MODEL; HISTOPATHOLOGY; INTERMETHOD COMPARISON; MALE; NERVE COMPRESSION; NERVE DECOMPRESSION; NERVE REGENERATION; NEURECTOMY; NEUROPROTECTION; NONHUMAN; RAT; SCIATIC NERVE; SOLEUS MUSCLE; TREATMENT DURATION; TREATMENT OUTCOME; ANIMAL; CHRONIC DISEASE; DECOMPRESSION SURGERY; DRUG EFFECT; HEMISPHERIC DOMINANCE; NERVE FIBER; ORGAN SIZE; PATHOLOGY; PHYSIOLOGY; RANDOMIZATION; SCIATIC NEUROPATHY; SKELETAL MUSCLE;

ACETYLCARNITINE; ANIMALS; AXONS; CHRONIC DISEASE; DECOMPRESSION, SURGICAL; DISEASE MODELS, ANIMAL; FUNCTIONAL LATERALITY; MALE; MUSCLE, SKELETAL; NERVE COMPRESSION SYNDROMES; NERVE REGENERATION; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; ORGAN SIZE; RANDOM ALLOCATION; RATS; SCIATIC NERVE; SCIATIC NEUROPATHY;

EID: 40149110250     PISSN: 10195149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Amadio PC: The Mayo Clinic and carpal tunnel syndrome. Mayo Clin Proc 67:42-8,1992
2. Bahadori MH, Al-Tiraihi T, Valojerdi MR. Sciatic nerve transection in neonatal rats induces apoptotic neuronal death in L5 dorsal root ganglion. J Neurocytol 30(2):125-30, 2001
3. Bergmark M, Kanje M, Widerberg A, Dahlin LB. Experimental nerve compression and upregulation of CPON in DRG. NeuroRapor 4;12(17):3783-6, 2001
4. Bigini P, Larini S, Pasquali C, Muzio V, Mennini T. Acetyl-L carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons.Neurosci Lett 6;329(3):334-8, 2002
5. Binienda ZK. Neuro protective effects of L-carnitine in induced mitochondrial dysfunction. Ann N Y Acad Sci 993:289-95; discussion 345-9, 2003
6. Bora FW Jr, Osterman AL. Compression neuropathy. Clin Orthop 163:20-32, 1982
7. Bremer J. The role of carnitine in intracellular metabolism. J Clin Chem Clin Biohem 28(5):297-301,1990
8. Castaneda F, Kinne RK. Omental graft improves functional recovery of transected peripheral nerve. Muscle Nerve 26(4):527-32, 2002
9. Castorina M, Ambrosini AM, Giuliani A, Pacifici L, Ramacci MT, Angelucci L. Acluster analysis study of acetyl-L-carnitine effect on NMDA receptors in aging. Exp Gerontol 28(6):537-48, 1993
10. Chauhan NB, Siegel GJ. Effect of PPF and ALCAR on the induction of NGF- and p75- mRNA and on APP processing in Tg2576 brain. Neurochem Int 43(3):225-33, 2003
11. De Angelis C, Scarfo C, Falcinelli M, Perna E, Ramacci MT, Angelucci L. Age- and trauma-dependent modifications of neuromuscular junction and skeletal muscle structure in the rat. Effects of long-term treatment with Acetyl-L-Carnitine. Mech Ageing Dev 3;85(1):37-53, 1995
12. De Grandis D, Santoro L, Di Benedetto P. L-acetylcarnitine in the treatment of patients with peripheral neuropathies. Clin Drug Invest 10:317-322, 1995
13. Dhitavat S, Ortiz D, Shea TB, Rivera ER. Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels. Neurochem Res 27(6):501-5, 2002
14. Dolezal V, Tucek S. Utilization of citrate, acetylcarnitine acetate, pyruvate and glucose for the synthesis of acetylcholine in rat brain slices. J Neurochem 36:1323-30, 1981
15. Evans GR. Challenges to nerve regeneration. Semin Surg Oncol 19:312-318, 2000
16. Foreman PJ, Perez-Polo JR, Angelucci L, Ramacci MT, Taglialatela G. Effects of acetyl-L-carnitine treatment and stress exposure on the nerve growth factor receptor (p75NGFR) mRNA level in the central nervous system of aged rats. Prog Neuropsychopharmacol Biol Psychiatry 19(1):117-33, 1995
17. Forloni G, Angeretti N, Smiroldo S. Neuroprotective activity of acetyl-L-carnitine: studies in vitro. J Neurosci Res 37(1):92-6, 1994
18. Formenti A, Arrigoni E, Sansone V, Arrigoni Martelli E, Mancia M. Effects of acetyl-L-carnitine on the survival of adult rat sensory neurons in primary cultures. Int J Dev Neurosci 10(3):207-9, 1992
19. Fritz IB, Marquis NR. The role of acylcarnitine esters and carnitine palmityltransferase in the transport of fatty acyl groups across mitochondrial membranes. Proc Nat Acad Sci 54:1226-33, 1965
20. Fowler TS, Ochoa J. Unmyelinated fibers in normal and compressed peripheral nerves of the baboon: A Quantitative electron microscopic study. Neuropath Applied Neurobiol 23:247-254, 1975
21. Gelberman RH, Rydevik BL, Pess GM, Szabo RM, Lundborg G. Carpal tunnel syndrome. A scientific basis for clinical care. Orthop Clin North Am 19(1):115-24, 1988
22. Ghelardini C, Galeotti N, Calvani M, Mosconi L, Nicolai R, Bartolini A. Acetyl-l-carnitine induces muscarinic antinocieption in mice and rats. Neuropharmacology 43(7):1180-7, 2002
23. Goettl VM, Neff NH, Hadjiconstantinou M. Sciatic nerve axotomy in aged rats: response of motoneurons and the effect of GM1 ganglioside treatment. Brain Res 4;968(1):44-53, 2003
24. Haldeman S, Meyer BJ: The effect of experimental constriction on the structure of the sciatic nerve. S Afr Med J 8 44(31):888-92, 1970
25. Hart AM, Wiberg M, Youle M, Terenghi G. Systemic acetyl-L-carnitine eliminates sen sory neuronal loss after peripheral axotomy: a new clinical approach in the management of peripheral nerve trauma. Exp Brain Res 145(2):182-9, 2002
26. Inano A, Sai Y, Nikaido H, Hasimoto N, Asano M, Tsuji A, Tamai I. Acetyl-L-carnitine permeability across the blood-brain barrier and involvement of carnitine transporter OCTN2. Biopharm Drug Dispos 24(8):357-65, 2003
27. Janiri L, Tempesta E. A pharmacological profile of the effects of carnitine and acetylcarnitine on the central nervous system. Int J Clin Pharm Res 111(4);295-306, 1983.
28. Kano M, Kawakami T, Hori H, Hashimoto Y, Tao Y, Ishikawa Y, Takenaka T. Effects of ALCAR on the fast axoplasmic transport in cultured sensory neurons of streptozotocin-induced diabetic rats. Neurosci Res 33(3):207-13, 1999
29. Levine J, Panchalingam K, McClure RJ, Gershon S, Pettegrew JW. Effects of acetyl-L-carnitine and myo-inositol on high-energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P-NMR-spectroscopy study. Neurochem Res 28(5):687-90, 2003
30. Ljungberg C, Novikov L, Kellerth JO, Ebendal T, Wiberg M. The neurotrophins NGF and NT-3 reduce sensory neuronal loss in adult rat after peripheral nerve lesion. Neurosci Lett 26;262(1):29-32, 1999
31. Ma J, Novikov LN, Kellerth JO, Wiberg M. Early nerve repair after injury to the postganglionic plexus: an experimental study of sensory and motor neuronal survival in adult rats. Scand J Plast Reconstr Surg Hand Surg 37(1):1-9, 2003
32. Mackinnon SE, Dellon AL, Hudson AR, Hunter DA. Chronic nerve compression- an experimental model in the rat. Ann Plast Surg 13(2):112-20, 1984
33. Mazzio E, Yoon KJ, Soliman KF. Acetyl-L-carnitine cytoprotection against 1- methyl-4-phenylpyridinium toxicity in neuroblastoma cells. Biochem Pharmacolv 66(2):297-306, 2003
34. Mc Daniel MA, Maier SF, Einstein GO. "Brain-specific" nutrients: a memory cure? Nutrition 9 (12):957-75, 2003
35. McKay Hart A, Wiberg M, Terenghi G. Pharmacological enhancement of peripheral nerve regeneration in the rat by systemic acetyl-L-carnitine treatment. Neurosci Lett1 6;(3):181-5, 2002
36. Ori C, Freo U, Pizzolato G, Dam M. Effects of acetyl-L-carnitine on regional cerebral glucose metabolism in awake rats. Brain Res 4;951(2):330-5, 2002
37. Rao KV, Qureshi IA. Reduction in the MK-801 binding sites of the NMDAsub-type of glutamate receptor in a mouse model of congenital hyperammonemia: prevention by acetyl-L-carnitine. Neuropharmacology 38(3):383-94, 1999
38. Shu N. The effect of neurolysis on the recovery of experimentally induced entrapment neuropathy. Nippon Seikeigeka Gakkai Zasshi 69(7):517-27,1995
39. Taglialatela G, Angelucci L, Ramacci MT, Werrbach-Perez K, Jackson GR, Perez-Polo JR. Stimulation of nerve growth factor receptors in PC12 by acetyl-L-carnitine. Biochem Pharmaco l4;44(3):577-85, 1992
40. Weisl H, Osborne GV. The pathological changes in rats' nerves subject to moderate compression. J Bone Joint Surg Br 46:297-306, 1964
41. Wiberg M, Ljungberg C, O'Byrne A, Brown R, Whitworth I, Liss A, et al:Primary sensory neuron survival following targeted administration of nerve growth factor to an injured nerve. Scand J Plast Reconstr Surg Hand Surg 33(4):387-92, 1999
42. Wilson AD, Hart A, Brannstrom T, Wiberg M, Terenghi G. Primary sensory neuronal rescue with systemic acetyl-L-carnitine following peripheral axotomy. A dose- response analysis. Br J Plast Surg 56(8):732-9, 2003
43. Yasui F, Matsugo S, Ishibashi M, Kajita T, Ezashi Y, Oomura Y, et al: Effects of chronic acetyl-L-carnitine treatment on brain lipid hydroperoxide level and passive avoidance learning in senescence-accelerated mice. Neurosci Lett 16;334(3):177-80, 2002
44. Yavuzer R, Ayhan S, Latifoglu O, Atabay K. Turnover epineural sheath tube in Primary repair of peripheral nerves. Ann Plast Surg 48 (4): 392-400, 2000